Name: Central Jersey Urgent Care
Price range: $

732-250-9550

Current Wait : minutes

Home » Meet Our Physicians

Dr. Arti Patel

Dr. Arti Patel was born in western Pennsylvania and graduated at Case Western Reserve University with a degree in Biomedical Engineering. She then pursued her medical degree at St. George’s University and graduated with honors. Afterwards, she completed her Emergency Medicine residency from Newark Beth Israel Medical Center. She has been practicing Emergency and Urgent care medicine for over 5 years. She is a highly skilled physician who is Board certified in Emergency Medicine. When she gets a spare moment, Dr. Patel enjoys setting new personal records on her Peloton, trying new healthy recipes, binge watching Netlfix with her husband, and exploring the world with her friends and family.

Dr. Michelle Chang

Dr. Michelle Chang completed her emergency medicine residency at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ where she was the Administrative Chief resident. She continues to work as an emergency medicine physician at Rutgers Robert Wood Johnson University Hospital along with working at Central Jersey Urgent Care. This brings her valuable experience in high quality, comprehensive patient care for both adult and pediatric patients. During her free time, Dr. Change enjoys spending time with her husband, family and dog, going on hikes, swimming, and surfing.

Get your latest COVID-19 and FLU/RSV Test Results

Please search for your test results in order to print them.

Testing Information

Your test was performed using one of the machines below:

Genesis Laboratory
Testing was performed using either of the following machines Thermo Fisher TaqMan 2019-nCoV Assay Kit v1, TaqMan 2019-nCoV Control Kit v1 Test, TaqPath COVID-19 Combo Kit and/ or Panther Fusion®️ SARS-CoV-2 Assay Kit. Positive results do not rule out co-infection with organisms not included in the Thermo Fisher TaqMan 2019-nCoV Assay Kit v1 and TaqMan 2019-nCoV Control Kit v1, TaqPath COVID-19 Combo Kit and/ or Panther Fusion®️ SARS-CoV-2 Assay Kit. The agent detected may not be the definite cause of this disease. This assay is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA). This test is only authorized for the duration of time of the declaration and for the detection of SARSCoV-2 RNS virus and/or diagnosis of COVID-19 infection under section 564 (b)(1) of the act, 21 U.S.C.360bbb-3(b)(1) unless the authorization is terminated or revoked sooner.
Clarity Laboratory
Virokey SARS CoV-2 real time PCR assay for detection of SARS CoV-2 from nasopharyngeal and oropharyngeal specimen was developed and its performance characteristics determined by Clarity Labs. The EUA approval #EU201790. This test is approved by CLIA, NJDOH and NYDOH. This test has been validated in accordance to FDA’s guidance document:”Policy for Diagnosis testing in laboratory verified to perform High complexity testing under CLIA prior to Emergency Use Authorization for Coronavirus disease-2019 during the public health emergency issued on February 29th 2020”. Negative results for symptomatic patients does not rule out the possibility of other bacterial or viral infections. Negative results does not rule out possibility of prior viral exposure. When Flag AB: Abnormal

NOTE: Results are uploaded each night, so if you don't see the results, try again tomorrow morning. If you have not found the test results after 5 days, please contact our office at (732) 781-0244 and select the office you tested.